Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117752 · ClinicalTrials.gov registry record · Phase 1
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
A Phase 1 study, sponsored by Almirall, S.A..
- Completed
- Registry status
- Phase 1
- Development phase
- 237
- Enrollment target
NCT02117752: Completed Phase 1 study, sponsored by Almirall, S.A..
NCT02117752 is a Phase 1 study that has completed, run by Almirall, S.A.. The registered enrollment target is 237 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (295% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02117752, a Phase 1 study, has completed, sponsored by Almirall, S.A..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 237 participants
- Enrollment target
Study Summary
This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
Interventions
- DRUG Normal saline
- DRUG dapsone gel
- DRUG dapsone gel vehicle
- DRUG sodium lauryl sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
What the finished NCT02117752 record still lists
NCT02117752 is an interventional study that assigns participants to a tested intervention. The registered 237 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (295% higher).
The record links to 0 conditions, and to 4 interventions - of which Normal saline is the first listed.
NCT02117752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02117752 about?
NCT02117752 is a clinical study titled "Dermal Tolerability of Dapsone Gel in Healthy Volunteers". This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
What is the current status of trial NCT02117752?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 237 participants. The study started on 2014-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02117752?
The interventions under investigation include: Normal saline (DRUG), dapsone gel (DRUG), dapsone gel vehicle (DRUG), sodium lauryl sulfate (DRUG).
Who is sponsoring clinical trial NCT02117752?
This trial is sponsored by Almirall, S.A., which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02117752's enrollment target sits among peer trials
237 212th of 2000 higher than 1,789 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05974176 · 237 participants · NA
Considering Racial and Acculturation Stress in Addressing Trauma
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia